Title |
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria
|
---|---|
Published in |
Frontiers in Microbiology, April 2017
|
DOI | 10.3389/fmicb.2017.00681 |
Pubmed ID | |
Authors |
Mohammad J. Nasiri, Mehri Haeili, Mona Ghazi, Hossein Goudarzi, Ali Pormohammad, Abbas A. Imani Fooladi, Mohammad M. Feizabadi |
Abstract |
Infectious diseases caused by clinically important Mycobacteria continue to be an important public health problem worldwide primarily due to emergence of drug resistance crisis. In recent years, the control of tuberculosis (TB), the disease caused by Mycobacterium tuberculosis (MTB), is hampered by the emergence of multidrug resistance (MDR), defined as resistance to at least isoniazid (INH) and rifampicin (RIF), two key drugs in the treatment of the disease. Despite the availability of curative anti-TB therapy, inappropriate and inadequate treatment has allowed MTB to acquire resistance to the most important anti-TB drugs. Likewise, for most mycobacteria other than MTB, the outcome of drug treatment is poor and is likely related to the high levels of antibiotic resistance. Thus, a better knowledge of the underlying mechanisms of drug resistance in mycobacteria could aid not only to select the best therapeutic options but also to develop novel drugs that can overwhelm the existing resistance mechanisms. In this article, we review the distinctive mechanisms of antibiotic resistance in mycobacteria. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 25% |
Greece | 1 | 13% |
Uganda | 1 | 13% |
Unknown | 4 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Scientists | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | <1% |
Germany | 1 | <1% |
Unknown | 327 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 55 | 17% |
Student > Ph. D. Student | 47 | 14% |
Student > Bachelor | 34 | 10% |
Researcher | 32 | 10% |
Student > Doctoral Student | 17 | 5% |
Other | 43 | 13% |
Unknown | 101 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 67 | 20% |
Immunology and Microbiology | 42 | 13% |
Agricultural and Biological Sciences | 31 | 9% |
Medicine and Dentistry | 28 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 23 | 7% |
Other | 30 | 9% |
Unknown | 108 | 33% |